Mayne Pharma | MYX - Current Assets


Mayne Pharma reported AUD460.59M in Current Assets for its fiscal semester ending in June of 2024.





Current Assets Change Date
Ansell USD 1.11B 5.2M Dec/2025
Avita Medical AUD 35.49M 760K Dec/2025
Cochlear AUD 1.37B 43.9M Dec/2025
CSL USD 11.85B 1000K Dec/2025
Healius AUD 1.04B 737.9M Dec/2024
Integral Diagnostics AUD 74.82M 9.15M Jun/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Nanosonics AUD 234.13M 8.81M Dec/2025
Polynovo AUD 69.23M 7.87M Dec/2025
Ramsay Health Care AUD 3.56B 480.3M Dec/2025
ResMed USD 4.06B 245.26M Mar/2026
Sigma Healthcare AUD 2.91B 2B Dec/2025
Sonic Healthcare AUD 2.3B 52.76M Dec/2024
Telix Pharmaceuticals AUD 330.28M 67.73M Dec/2025